ImmunityBio, Inc.
IBRX
$2.84
$0.176.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -129.65M | -59.16M | -85.73M | -134.56M | -134.11M |
| Total Depreciation and Amortization | 3.83M | 4.14M | 4.46M | 4.41M | 4.56M |
| Total Amortization of Deferred Charges | -- | 5.01M | 6.20M | 5.83M | 5.55M |
| Total Other Non-Cash Items | 61.95M | -24.29M | -13.64M | 18.62M | 20.92M |
| Change in Net Operating Assets | -22.04M | -10.84M | -10.05M | 5.36M | -3.89M |
| Cash from Operations | -85.91M | -85.14M | -98.76M | -100.35M | -106.98M |
| Capital Expenditure | -1.12M | -2.11M | -2.79M | -724.00K | -1.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.25M | 11.95M | 67.82M | -50.77M | -34.36M |
| Cash from Investing | 4.13M | 9.83M | 65.03M | -51.49M | -35.62M |
| Total Debt Issued | -- | 0.00 | 96.96M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -22.00K | -21.00K | -21.00K |
| Issuance of Common Stock | 220.00K | 107.73M | 15.90M | 52.45M | 14.12M |
| Repurchase of Common Stock | -1.20M | -803.00K | -299.00K | -496.00K | -3.87M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -96.96M | 96.96M | -3.00K |
| Cash from Financing | -982.00K | 106.93M | 15.58M | 148.89M | 10.23M |
| Foreign Exchange rate Adjustments | -10.00K | -7.00K | 11.00K | 12.00K | -39.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.77M | 31.61M | -18.14M | -2.93M | -132.42M |